Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
27 Sep 2024
Historique:
medline: 14 10 2024
pubmed: 14 10 2024
entrez: 14 10 2024
Statut: epublish

Résumé

Nosocomial bacterial infections have become increasingly challenging due to their inherent resistance to antibiotics. The emergence of multidrug-resistant bacterial strains in hospitals has been attributed to the extensive and varied use of antibiotics, further exacerbating the problem of antibiotic resistance. Metal nanomaterials have been widely studied as an alternative solution for eradicating antibiotic-resistant bacterial cells. Metallic nanoparticles attack bacterial cells through various mechanisms, such as the release of antibacterial ions, generation of reactive oxygen species, or physical disruption, against which bacteria cannot develop resistance. Among the actively researched antimicrobial metal nanoparticles, zinc oxide nanoparticles, which are FDA-approved, are known for their biocompatibility and antibacterial properties. In this study, we focused on successfully developing a precipitation method for synthesizing zinc oxide nanoparticles, analyzing the properties of these nanoparticles, and conducting antimicrobial tests. Zinc oxide nanoparticles were characterized using transmission electron microscopy (TEM), dynamic light scattering (DLS), ultraviolet/visible spectroscopy, and X-ray diffraction (XRD). Antibacterial tests were conducted using the broth microdilution test with the multidrug-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. This study demonstrated the potential of zinc oxide nanoparticles in inhibiting the proliferation of antibiotic-resistant bacteria.

Identifiants

pubmed: 39400132
doi: 10.3791/66725
doi:

Substances chimiques

Zinc Oxide SOI2LOH54Z
Anti-Bacterial Agents 0

Types de publication

Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Jongjun Park (J)

School of Integrative Engineering, Chung-Ang University.

Gahyun Lee (G)

School of Integrative Engineering, Chung-Ang University.

Yonghyun Choi (Y)

School of Integrative Engineering, Chung-Ang University; Feynman Institute of Technology, Nanomedicine Corporation; Department of Chemical Science and Engineering, Tokyo Institute of Technology.

Jiwon Kim (J)

School of Integrative Engineering, Chung-Ang University.

Seongeun Park (S)

School of Integrative Engineering, Chung-Ang University.

Hee-Young Lee (HY)

Department of Chemical Engineering, Kumoh National Institute of Technology; lhysshr@kumoh.ac.kr.

Jonghoon Choi (J)

School of Integrative Engineering, Chung-Ang University; Feynman Institute of Technology, Nanomedicine Corporation; nanomed@cau.ac.kr.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Classifications MeSH